Maximilian von Roeder1, Johannes Tammo Kowallick2,3, Karl-Philipp Rommel1, Stephan Blazek1, Christian Besler1, Karl Fengler1, Joachim Lotz2,3, Gerd Hasenfuß4,3, Christian Lücke5, Matthias Gutberlet5, Holger Thiele1, Andreas Schuster4,3,6, Philipp Lurz7. 1. Department of Internal Medicine/Cardiology, Heart Center Leipzig, University Hospital, Struempellstrasse 39, 04289, Leipzig, Germany. 2. Institute for Diagnostic and Interventional Radiology, Georg-August University, Göttingen, Germany. 3. DZHK (German Centre for Cardiovascular Research Partner Site Göttingen), Göttingen, Germany. 4. Department of Cardiology and Pneumology, Georg-August University, Göttingen, Germany. 5. Department of Radiology, Heart Center Leipzig, University Hospital, Leipzig, Germany. 6. Department of Cardiology, Royal North Shore Hospital, The Kolling Institute, Northern Clinical School, University of Sydney, Sydney, Australia. 7. Department of Internal Medicine/Cardiology, Heart Center Leipzig, University Hospital, Struempellstrasse 39, 04289, Leipzig, Germany. philipp.lurz@medizin.uni-leipzig.de.
Abstract
BACKGROUND: Right ventricular (RV) function is prognostically relevant in heart failure with preserved ejection fraction (HFpEF) but data on profound assessment of RV and right atrial (RA) interaction in HFpEF are lacking. The current study characterizes RV and RA interaction using invasive pressure-volume-loop analysis and cardiac magnetic resonance imaging (CMR) data. METHODS AND RESULTS: We performed CMR and myocardial feature-tracking in 24 HFpEF patients and 12 patients without HFpEF. Invasive pressure-volume-loops were obtained to evaluate systolic and diastolic RV properties. RV early filling was determined from CMR RV volume-time curves. RV systolic function was slightly increased in HFpEF (RV EF 68 ± 8 vs. 60 ± 9%, p = 0.01), while no differences in RV stroke volume were found (45 ± 7 vs 42 ± 9 ml/m2, p = 0.32). RV early filling was decreased in HFpEF (21 ± 11 vs. 40 ± 11% of RV filling volume, p < 0.01) and RV early filling was the strongest predictor for VO2max even after inclusion of invasively derived RV stiffness and relaxation constant (Beta 0.63, p < 0.01). RA conduit-function was lower in HFpEF (RA conduit-strain - 11 ± 5 vs. - 16 ± 4%, p < 0.01) while RA booster-pump-function was increased (RA active-strain - 18 ± 6 vs. - 12 ± 6%, p = 0.01) as a compensation. RV filling was associated with RA conduit-function (r = - 0.55, p < 0.01) but not with invasively derived RV relaxation constant. CONCLUSION: In compensated HFpEF patients RV early filling was impaired and compensated by increased RA booster pump function, while RV systolic function was preserved. Impaired RV diastology and RA-RV interaction were linked to impaired exercise tolerance and RA-RV-coupling seems to be independent of RV relaxation, suggestive of an independent pathophysiological contribution of RA dysfunction in HFpEF. CLINICAL-TRIAL-REGISTRATION: NCT02459626 (www.clinicaltrials.gov).
BACKGROUND: Right ventricular (RV) function is prognostically relevant in heart failure with preserved ejection fraction (HFpEF) but data on profound assessment of RV and right atrial (RA) interaction in HFpEF are lacking. The current study characterizes RV and RA interaction using invasive pressure-volume-loop analysis and cardiac magnetic resonance imaging (CMR) data. METHODS AND RESULTS: We performed CMR and myocardial feature-tracking in 24 HFpEF patients and 12 patients without HFpEF. Invasive pressure-volume-loops were obtained to evaluate systolic and diastolic RV properties. RV early filling was determined from CMR RV volume-time curves. RV systolic function was slightly increased in HFpEF (RV EF 68 ± 8 vs. 60 ± 9%, p = 0.01), while no differences in RVstroke volume were found (45 ± 7 vs 42 ± 9 ml/m2, p = 0.32). RV early filling was decreased in HFpEF (21 ± 11 vs. 40 ± 11% of RV filling volume, p < 0.01) and RV early filling was the strongest predictor for VO2max even after inclusion of invasively derived RV stiffness and relaxation constant (Beta 0.63, p < 0.01). RA conduit-function was lower in HFpEF (RA conduit-strain - 11 ± 5 vs. - 16 ± 4%, p < 0.01) while RA booster-pump-function was increased (RA active-strain - 18 ± 6 vs. - 12 ± 6%, p = 0.01) as a compensation. RV filling was associated with RA conduit-function (r = - 0.55, p < 0.01) but not with invasively derived RV relaxation constant. CONCLUSION: In compensated HFpEF patientsRV early filling was impaired and compensated by increased RA booster pump function, while RV systolic function was preserved. Impaired RV diastology and RA-RV interaction were linked to impaired exercise tolerance and RA-RV-coupling seems to be independent of RV relaxation, suggestive of an independent pathophysiological contribution of RA dysfunction in HFpEF. CLINICAL-TRIAL-REGISTRATION: NCT02459626 (www.clinicaltrials.gov).
Entities:
Keywords:
Feature tracking; Heart failure; Magnetic resonance imaging; Preserved ejection fraction; Pressure–volume-loops; Right atrium; Right heart
Authors: Philipp Lurz; Rajesh Puranik; Johannes Nordmeyer; Vivek Muthurangu; Michael S Hansen; Silvia Schievano; Jan Marek; Philipp Bonhoeffer; Andrew M Taylor Journal: Eur Heart J Date: 2009-06-26 Impact factor: 29.983
Authors: Gabriela Querejeta Roca; Patricia Campbell; Brian Claggett; Scott D Solomon; Amil M Shah Journal: Circ Cardiovasc Imaging Date: 2015-11 Impact factor: 7.792
Authors: Ted Feldman; Laura Mauri; Rami Kahwash; Sheldon Litwin; Mark J Ricciardi; Pim van der Harst; Martin Penicka; Peter S Fail; David M Kaye; Mark C Petrie; Anupam Basuray; Scott L Hummel; Rhondalyn Forde-McLean; Christopher D Nielsen; Scott Lilly; Joseph M Massaro; Daniel Burkhoff; Sanjiv J Shah Journal: Circulation Date: 2017-11-15 Impact factor: 29.690
Authors: Thomas M Gorter; Dirk J van Veldhuisen; Johann Bauersachs; Barry A Borlaug; Jelena Celutkiene; Andrew J S Coats; Marisa G Crespo-Leiro; Marco Guazzi; Veli-Pekka Harjola; Stephane Heymans; Loreena Hill; Mitja Lainscak; Carolyn S P Lam; Lars H Lund; Alexander R Lyon; Alexandre Mebazaa; Christian Mueller; Walter J Paulus; Burkert Pieske; Massimo F Piepoli; Frank Ruschitzka; Frans H Rutten; Petar M Seferovic; Scott D Solomon; Sanjiv J Shah; Filippos Triposkiadis; Rolf Wachter; Carsten Tschöpe; Rudolf A de Boer Journal: Eur J Heart Fail Date: 2017-10-16 Impact factor: 15.534
Authors: Philipp Lurz; Frank T Riede; Andrew M Taylor; Robert Wagner; Johannes Nordmeyer; Sachin Khambadkone; Peter Kinzel; Graham Derrick; Gerhard Schuler; Philipp Bonhoeffer; Alessandro Giardini; Ingo Daehnert Journal: Int J Cardiol Date: 2014-09-22 Impact factor: 4.164
Authors: Thomas M Gorter; Elke S Hoendermis; Dirk J van Veldhuisen; Adriaan A Voors; Carolyn S P Lam; Bastiaan Geelhoed; Tineke P Willems; Joost P van Melle Journal: Eur J Heart Fail Date: 2016-09-20 Impact factor: 15.534
Authors: Roman Johannes Gertz; Torben Lange; Johannes Tammo Kowallick; Sören Jan Backhaus; Michael Steinmetz; Wieland Staab; Shelby Kutty; Gerd Hasenfuß; Joachim Lotz; Andreas Schuster Journal: PLoS One Date: 2018-03-14 Impact factor: 3.240
Authors: Michael I Brener; Amirali Masoumi; Vivian G Ng; Khodr Tello; Marcelo B Bastos; William K Cornwell; Steven Hsu; Ryan J Tedford; Philipp Lurz; Karl-Philipp Rommel; Karl-Patrik Kresoja; Sherif F Nagueh; Manreet K Kanwar; Navin K Kapur; Gurumurthy Hiremath; Mohammad Sarraf; Antoon J M Van Den Enden; Nicolas M Van Mieghem; Paul M Heerdt; Rebecca T Hahn; Susheel K Kodali; Gabriel T Sayer; Nir Uriel; Daniel Burkhoff Journal: Circ Heart Fail Date: 2021-12-29 Impact factor: 8.790
Authors: M Louis Handoko; Frances S de Man; Jessie van Wezenbeek; Azar Kianzad; Arno van de Bovenkamp; Jeroen Wessels; Sophia A Mouratoglou; Natalia J Braams; Samara M A Jansen; Eva Meulblok; Lilian J Meijboom; J Tim Marcus; Anton Vonk Noordegraaf; Marie José Goumans; Harm Jan Bogaard Journal: Circ Heart Fail Date: 2021-12-23 Impact factor: 8.790
Authors: Maximilian von Roeder; Stephan Blazek; Karl-Philipp Rommel; Karl-Patrik Kresoja; Guglielmo Gioia; Luise Mentzel; Julia Anna Lurz; Christian Besler; Karl Fengler; Gerhard Hindricks; Steffen Desch; Holger Thiele; Philipp Lurz Journal: Clin Res Cardiol Date: 2021-12-21 Impact factor: 6.138
Authors: Andreas Schuster; Sören J Backhaus; Thomas Stiermaier; Jenny-Lou Navarra; Johannes Uhlig; Karl-Philipp Rommel; Alexander Koschalka; Johannes T Kowallick; Boris Bigalke; Shelby Kutty; Matthias Gutberlet; Gerd Hasenfuß; Holger Thiele; Ingo Eitel Journal: J Clin Med Date: 2020-01-12 Impact factor: 4.241